How will US Democratic presidential candidates lower drug prices for seniors if they become President? This is a question many will be asking ahead of the US elections.
Seventeen candidates recently spoke to advocacy group AARP - the American Association of Retired Persons - and the Des Moines Register about high prescription costs and their broader health care plan. Here are some of their views.
Former Vice President Joe Biden: “I would set up an independent commission at the Department of Health and Human Services that would bring in experts from around the country that would, in fact, take a look at the research and the cost of going in to develop that drug, and set the initial price of that drug. After that, if they get a patent on that drug … they cannot raise it beyond the cost of inflation at that time.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze